Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
-
-
-
-
-
-
Cara Therapeutics (CARA) PT Raised to $39 at Piper Jaffray
-
-
-
-
-
-
-
Cara Therapeutics Announces Proposed Offering of Common Stock
-
-
-
-
-
-
-
Cara Therapeutics Reports Second Quarter 2018 Financial Results
-
-
-
-
-
-
-
Cara Therapeutics (CARA) Announces Proposed 4.5M Share Common Offering
-
-
-
-
-
-
-
Cara Therapeutics (CARA): Data Isn't As Bad As It Seems - Piper
-
-
-
-
-
-
-
Piper Jaffray Reiterates Overweight Rating and $23 PT on Cara Therapeutics (CARA) Following Positive Phase 2/3 Trials of CR845
-
-
-
-
-
-
-
Piper Jaffray Reiterates Bullish View on Cara Therapeutics (CARA) as Clinical Hold Lifted
-
20,795 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All